| Macrophage activation-like syndrome: an immunological entity associated with rapid progression to death in sepsis E Kyriazopoulou, K Leventogiannis, A Norrby-Teglund, G Dimopoulos, ... BMC medicine 15, 1-10, 2017 | 169 | 2017 |
| ACTIVATE-2: a double-blind randomized trial of BCG vaccination against COVID-19 in individuals at risk M Tsilika, E Taks, K Dolianitis, A Kotsaki, K Leventogiannis, C Damoulari, ... Frontiers in immunology 13, 873067, 2022 | 90 | 2022 |
| Effect of a preparation of four probiotics on symptoms of patients with irritable bowel syndrome: association with intestinal bacterial overgrowth K Leventogiannis, P Gkolfakis, G Spithakis, A Tsatali, A Pistiki, A Sioulas, ... Probiotics and antimicrobial proteins 11, 627-634, 2019 | 55 | 2019 |
| Toward personalized immunotherapy in sepsis: The PROVIDE randomized clinical trial K Leventogiannis, E Kyriazopoulou, N Antonakos, A Kotsaki, I Tsangaris, ... Cell Reports Medicine 3 (11), 2022 | 43 | 2022 |
| Validation of inflammopathic, adaptive, and coagulopathic sepsis endotypes in coronavirus disease 2019 TE Sweeney, O Liesenfeld, J Wacker, YD He, D Rawling, M Remmel, ... Critical Care Medicine 49 (2), e170-e178, 2021 | 32 | 2021 |
| Prognostic role of soluble urokinase plasminogen activator receptor at the emergency department: a position paper by the Hellenic sepsis study group D Velissaris, G Dimopoulos, J Parissis, Z Alexiou, N Antonakos, D Babalis, ... Infectious diseases and therapy 9, 407-416, 2020 | 32 | 2020 |
| Individualized significance of the− 251 a/T single nucleotide polymorphism of interleukin-8 in severe infections MD Georgitsi, V Vitoros, C Panou, I Tsangaris, E Aimoniotou, NK Gatselis, ... European Journal of Clinical Microbiology & Infectious Diseases 35, 563-570, 2016 | 24 | 2016 |
| The association of TSH and thyroid hormones with lymphopenia in bacterial sepsis and COVID-19 I Grondman, AH de Nooijer, N Antonakos, NAF Janssen, M Mouktaroudi, ... The Journal of Clinical Endocrinology & Metabolism 106 (7), 1994-2009, 2021 | 18 | 2021 |
| Lessons from pathophysiology: Use of individualized combination treatments with immune interventional agents to tackle severe respiratory failure in patients with COVID-19 GN Dalekos, A Stefos, S Georgiadou, V Lygoura, A Michail, G Ntaios, ... European Journal of Internal Medicine 88, 52-62, 2021 | 15 | 2021 |
| Intravenous paracetamol as an antipyretic and analgesic medication: the significance of drug metabolism EJ Giamarellos-Bourboulis, A Spyridaki, A Savva, M Georgitsi, ... Journal of pharmacological sciences 124 (2), 144-152, 2014 | 12 | 2014 |
| Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trial K Akinosoglou, A Kotsaki, IM Gounaridi, E Christaki, S Metallidis, ... EClinicalMedicine 56, 2023 | 11 | 2023 |
| A novel optical biosensor for the early diagnosis of sepsis and severe Covid-19: the PROUD study S Doulou, K Leventogiannis, M Tsilika, M Rodencal, K Katrini, ... BMC Infectious Diseases 20, 1-10, 2020 | 7 | 2020 |
| Hellenic Sepsis Study G (2017) Macrophage activation-like syndrome: an immunological entity associated with rapid progression to death in sepsis E Kyriazopoulou, K Leventogiannis, A Norrby-Teglund, G Dimopoulos, ... BMC Med 15, 172, 0 | 4 | |
| Clinical evidence supporting ceftaroline fosamil and ceftobiprole for complicated skin and soft tissue infections K Leventogiannis, M Mouktaroudi, EJ Giamarellos-Bourboulis Current Opinion in Infectious Diseases 36 (2), 89-94, 2023 | 3 | 2023 |
| Presepsin as a diagnostic and prognostic biomarker of severe bacterial infections and COVID-19 E Kyriazopoulou, K Leventogiannis, G Tavoulareas, E Mainas, ... Scientific Reports 13 (1), 3814, 2023 | 3 | 2023 |
| An active new formulation of iron carried by aspartyl casein for iron-deficiency anemia: results of the ACCESS trial M Tsilika, J Mitrou, N Antonakos, IK Tseti, G Damoraki, K Leventogiannis, ... Annals of Hematology 102 (6), 1341-1349, 2023 | 1 | 2023 |
| Evaluation of the Novel Sepsis Biomarker Host-Derived Delta-like Canonical Notch Ligand 1—A Secondary Analysis of 405 Patients Suffering from Inflammatory or Infectious Diseases T Hölle, P Rehn, K Leventogiannis, A Kotsaki, T Kanni, N Antonakos, ... International Journal of Molecular Sciences 24 (11), 9164, 2023 | 1 | 2023 |
| Correction to: effect of a preparation of four probiotics on symptoms of patients with irritable bowel syndrome: association with intestinal bacterial overgrowth K Leventogiannis, P Gkolfakis, G Spithakis, A Tsatali, A Pistiki, A Sioulas, ... Probiotics and antimicrobial proteins 11, 635-637, 2019 | 1 | 2019 |
| Early suPAR-Guided Anakinra Treatment in COVID-19 Pneumonia: Subgroup Analyses and 90-Day Outcomes of the SAVE-MORE Trial K Akinosoglou, A Kotsaki, IM Gounaridi, E Christaki, S Metallidis, ... | | 2022 |
| Corrigendum: ACTIVATE-2: A double-blind randomized trial of BCG vaccination against COVID-19 in individuals at risk M Tsilika, E Taks, K Dolianitis, A Kotsaki, K Leventogiannis, C Damoulari, ... Frontiers in immunology 13, 1018384, 2022 | | 2022 |
